SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)

SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology advances 2022-08, Vol.4 (Supplement_1), p.i24-i24
Hauptverfasser: Xi, Jing, Luo, Jingqing, O’Sullivan, Ciara, Chen, Nan, Stringer-Reasor, Erica, Ma, Cynthia, Campian, Jian
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page i24
container_issue Supplement_1
container_start_page i24
container_title Neuro-oncology advances
container_volume 4
creator Xi, Jing
Luo, Jingqing
O’Sullivan, Ciara
Chen, Nan
Stringer-Reasor, Erica
Ma, Cynthia
Campian, Jian
description
doi_str_mv 10.1093/noajnl/vdac078.092
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_noajnl_vdac078_092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_noajnl_vdac078_092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c872-70c379c1ea5f200d6be86db3562d681ce855874df2f2856a527f6acd289d5cec3</originalsourceid><addsrcrecordid>eNpNkEFrg0AUhJfSQkObP9DTOyYHk3V1dT2uZhMX1BXdtKQXMatCQ5oUhUJ_Sf9uDcmhpze8YYbhQ-jFxgsbB87ydK4Pp-Pyu6kN9tkCB-QOTYjnEIu4Abv_px_RdBgOGGNCXepiMkG_5a7Ulu1AHvNSgJRQ6u1qB2oNOhYQqTSUGddSZZdXInNVqpQnIAuZKS0ingHPVpCLNCxUIt-3KQ9hrQrQhcwTYWViM6ZfBYSF4KWGMRCJAmY6C6M5vEkdjw6XGaRCj_64oYRZmM6f0UNXH4d2ertPSK-FjmIrURsZ8cQyzCeWj43jB8Zua9oRjBtv3zKv2TvUI43HbNMySpnvNh3pCKNeTYnfebVpCAsaalrjPCFyrTX9eRj6tqu--o_Puv-pbFxd4FZXuNUNbjXCdf4AqJxj7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Oxford University Press (Open Access Collection)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Xi, Jing ; Luo, Jingqing ; O’Sullivan, Ciara ; Chen, Nan ; Stringer-Reasor, Erica ; Ma, Cynthia ; Campian, Jian</creator><creatorcontrib>Xi, Jing ; Luo, Jingqing ; O’Sullivan, Ciara ; Chen, Nan ; Stringer-Reasor, Erica ; Ma, Cynthia ; Campian, Jian</creatorcontrib><identifier>ISSN: 2632-2498</identifier><identifier>EISSN: 2632-2498</identifier><identifier>DOI: 10.1093/noajnl/vdac078.092</identifier><language>eng</language><ispartof>Neuro-oncology advances, 2022-08, Vol.4 (Supplement_1), p.i24-i24</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Xi, Jing</creatorcontrib><creatorcontrib>Luo, Jingqing</creatorcontrib><creatorcontrib>O’Sullivan, Ciara</creatorcontrib><creatorcontrib>Chen, Nan</creatorcontrib><creatorcontrib>Stringer-Reasor, Erica</creatorcontrib><creatorcontrib>Ma, Cynthia</creatorcontrib><creatorcontrib>Campian, Jian</creatorcontrib><title>SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)</title><title>Neuro-oncology advances</title><issn>2632-2498</issn><issn>2632-2498</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpNkEFrg0AUhJfSQkObP9DTOyYHk3V1dT2uZhMX1BXdtKQXMatCQ5oUhUJ_Sf9uDcmhpze8YYbhQ-jFxgsbB87ydK4Pp-Pyu6kN9tkCB-QOTYjnEIu4Abv_px_RdBgOGGNCXepiMkG_5a7Ulu1AHvNSgJRQ6u1qB2oNOhYQqTSUGddSZZdXInNVqpQnIAuZKS0ingHPVpCLNCxUIt-3KQ9hrQrQhcwTYWViM6ZfBYSF4KWGMRCJAmY6C6M5vEkdjw6XGaRCj_64oYRZmM6f0UNXH4d2ertPSK-FjmIrURsZ8cQyzCeWj43jB8Zua9oRjBtv3zKv2TvUI43HbNMySpnvNh3pCKNeTYnfebVpCAsaalrjPCFyrTX9eRj6tqu--o_Puv-pbFxd4FZXuNUNbjXCdf4AqJxj7w</recordid><startdate>20220805</startdate><enddate>20220805</enddate><creator>Xi, Jing</creator><creator>Luo, Jingqing</creator><creator>O’Sullivan, Ciara</creator><creator>Chen, Nan</creator><creator>Stringer-Reasor, Erica</creator><creator>Ma, Cynthia</creator><creator>Campian, Jian</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220805</creationdate><title>SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)</title><author>Xi, Jing ; Luo, Jingqing ; O’Sullivan, Ciara ; Chen, Nan ; Stringer-Reasor, Erica ; Ma, Cynthia ; Campian, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c872-70c379c1ea5f200d6be86db3562d681ce855874df2f2856a527f6acd289d5cec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xi, Jing</creatorcontrib><creatorcontrib>Luo, Jingqing</creatorcontrib><creatorcontrib>O’Sullivan, Ciara</creatorcontrib><creatorcontrib>Chen, Nan</creatorcontrib><creatorcontrib>Stringer-Reasor, Erica</creatorcontrib><creatorcontrib>Ma, Cynthia</creatorcontrib><creatorcontrib>Campian, Jian</creatorcontrib><collection>CrossRef</collection><jtitle>Neuro-oncology advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xi, Jing</au><au>Luo, Jingqing</au><au>O’Sullivan, Ciara</au><au>Chen, Nan</au><au>Stringer-Reasor, Erica</au><au>Ma, Cynthia</au><au>Campian, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)</atitle><jtitle>Neuro-oncology advances</jtitle><date>2022-08-05</date><risdate>2022</risdate><volume>4</volume><issue>Supplement_1</issue><spage>i24</spage><epage>i24</epage><pages>i24-i24</pages><issn>2632-2498</issn><eissn>2632-2498</eissn><doi>10.1093/noajnl/vdac078.092</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2632-2498
ispartof Neuro-oncology advances, 2022-08, Vol.4 (Supplement_1), p.i24-i24
issn 2632-2498
2632-2498
language eng
recordid cdi_crossref_primary_10_1093_noajnl_vdac078_092
source DOAJ Directory of Open Access Journals; Access via Oxford University Press (Open Access Collection); EZB-FREE-00999 freely available EZB journals; PubMed Central
title SYST-13 PHASE II STUDY OF THE COMBINATION OF LIPOSOMAL IRINOTECAN AND PEMBROLIZUMAB FOR TRIPLE-NEGATIVE BREAST CANCER (TNBC) WITH BRAIN METASTASES (BM)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T12%3A26%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SYST-13%20PHASE%20II%20STUDY%20OF%20THE%20COMBINATION%20OF%20LIPOSOMAL%20IRINOTECAN%20AND%20PEMBROLIZUMAB%20FOR%20TRIPLE-NEGATIVE%20BREAST%20CANCER%20(TNBC)%20WITH%20BRAIN%20METASTASES%20(BM)&rft.jtitle=Neuro-oncology%20advances&rft.au=Xi,%20Jing&rft.date=2022-08-05&rft.volume=4&rft.issue=Supplement_1&rft.spage=i24&rft.epage=i24&rft.pages=i24-i24&rft.issn=2632-2498&rft.eissn=2632-2498&rft_id=info:doi/10.1093/noajnl/vdac078.092&rft_dat=%3Ccrossref%3E10_1093_noajnl_vdac078_092%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true